China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design

China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design

Backgrounds Increased blood pressure (BP) for patients who had an acute ischaemic stroke is associated with poor functional outcome, however the optimal timing of antihypertensive therapy is unknown.Aims We aim to compare early antihypertensive treatment to delayed antihypertensive treatment for red...

Full description

Bibliographic Details
Main Authors: Liping Liu, Yongjun Wang, Yilong Wang, David Wang, Xia Meng, Yong Jiang, Yuesong Pan, Dacheng Liu, Penglian Wang, Jiang He, Yufei Wei, Tan Xu, Xuewei Xie, Aili Wang, Suwen Shen, Chongke Zhong, Yonghong Zhang
Format: Article
Language:English
Published: BMJ Publishing Group
Series:Stroke and Vascular Neurology
Online Access:https://svn.bmj.com/content/early/2021/03/16/svn-2020-000828.full

Internet

https://svn.bmj.com/content/early/2021/03/16/svn-2020-000828.full

Similar Items